is a topic covered in the Johns Hopkins Diabetes Guide
To view the entire topic, please sign in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
- Naltrexone/bupropion was approved as an adjunct to diet and exercise in adults with BMI ≥30 kg/m2 or ≥27 kg/m2 with one or more weight-related comorbidities to achieve weight loss.
-- To view the remaining sections of this topic, please sign in or purchase a subscription --
Last updated: August 22, 2017
TY - ELEC
T1 - Naltrexone/Buproprion
ID - 547197
A1 - Lee,Clare,M.D., MHS
AU - Pinto,Brian,Pharm.D.
Y1 - 2017/08/22/
PB - Johns Hopkins Diabetes Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547197/all/Naltrexone_Buproprion